Diplopia After an HOF Procedure: Causes and Management
- Artery
Quick facts
- Golden rule
- Double vision or any visual change after a facial injectable is a complaint that calls for immediate assessment, not watchful waiting.
- Possible causes
- Toxin diffusion to eye muscles, ischemia from vascular occlusion, orbital compression from swelling or hematoma, and neurological causes.
- Signs of urgency
- Vision loss, eye pain, disproportionate pain, red eye, sudden ptosis, severe headache or neurological signs.
- Professional's role
- Recognize, stop, activate the protocol, refer to ophthalmology and document.
"Doctor, I'm seeing double." Few sentences leave an orofacial harmonization (HOF) practice so quiet. Diplopia, or double vision, after a facial procedure is a symptom the professional must take seriously from the first word, because the possible causes range from transient and mild to time-critical and severe.
This page organizes review-level reasoning about causes, signs of urgency and referral management. It gives no doses, does not describe reversal technique and does not replace an ophthalmic assessment. The clinical decision belongs to the qualified professional, based on up-to-date protocols and the rules of their professional board.
What is diplopia and why does it happen?
Diplopia is the perception of two images of the same object. It can be binocular (it goes away when one eye is closed, usually from eye misalignment) or monocular (it persists with one eye only, usually from a problem in the eye itself). In post-procedure practice, the binocular type is the most relevant, and it usually points to dysfunction of the muscles or nerves that move the eyes.
The extraocular muscles are small, delicate and close to areas where we inject. Anything that changes the strength of one of them, the blood supply or the surrounding space can misalign the gaze. See the diplopia entry and its relation to amaurosis, which is vision loss.
What are the possible causes after an HOF procedure?
The table below organizes the main hypotheses, at a review level. It is not for reaching a diagnosis in the practice.
| Hypothesis | General mechanism | Typical context | Severity |
|---|---|---|---|
| Toxin diffusion | The toxin reaches muscles that move the eye, weakening them | Periorbital treatment, in the glabellar area or lateral to the eyes | Usually transient, but needs assessment |
| Vascular occlusion | Compromised blood supply to eye or orbital structures | Filler in high-risk areas such as glabella, nose, forehead, temple | Time-critical, possibly severe |
| Orbital swelling or hematoma | Compression of orbital structures | Periorbital procedures, trauma, coagulopathy | May be severe and require intervention |
| Neurological cause | Involvement of cranial nerves or the nervous system | Picture unrelated to the procedure or coincidental | May be severe |
| Unrelated factors | Eye strain, prior vision changes, medication use | Symptom coincident with the procedure | Variable |
Timing alone does not prove cause, but prudence says to treat it as related until assessed. For vascular mechanisms, see vascular occlusion, ophthalmic artery and central retinal artery. For the toxin context, see toxin diffusion and complications with botulinum toxin.
Which signs indicate urgency?
The presence of any of these items together with diplopia changes the approach: treat it as an emergency and refer. See visual complication after filler and the pages on occlusion by area, such as glabellar vascular occlusion and nasal vascular occlusion.
What should be done in the practice?
Preparation details are in HOF practice emergency kit, hyaluronidase in the practice and hospital transfer of the patient. The specific management is decided by the qualified professional, based on up-to-date protocols.
And when the cause is toxin and the picture is mild?
When the history is periorbital toxin, the diplopia is isolated, the patient is stable and there are no other alarm signs, diffusion to eye muscles is a plausible hypothesis. Even so, an ophthalmic assessment is recommended to confirm the picture and rule out other causes.
In these cases, management is supportive and based on follow-up: reassure honestly, explain that the toxin's effect is temporary, advise about activities that need visual attention (such as driving) while the symptom lasts, and keep in close contact. There is no routinely used antidote. If there is ptosis, see ptosis after botulinum toxin and heavy-looking eyes after toxin. Dry eye and difficulty closing the eye also deserve attention (see dry eye and lagophthalmos after toxin).
How can it be prevented?
Prevention starts in planning:
- know the periorbital anatomy and the high-risk areas (see periorbital anatomy for injectables and vascular danger zones of the face);
- respect the limits of indication and experience, referring what goes beyond them;
- keep the emergency kit and the written protocol;
- train the team with drills;
- inform the patient about rare but serious risks in the informed consent;
- tell the patient to contact the practice immediately for any visual symptom.
How should I talk with the patient and document?
Communication with the patient and family needs to be objective, humane and free of speculation. Acknowledge what is happening, explain the next steps and stay in contact. See communicating a complication to the patient and communicating suspected vascular occlusion to the patient.
Documentation covers times, complaints in the patient's own words, exam findings, products, actions, contacts made and outcome (see recording the complication in the patient record and adverse event reporting: Notivisa).
Frequently asked questions
Is diplopia after toxin around the eyes common?
It is not a common effect, but it is described as a rare adverse event when the toxin reaches the muscles that move the eye. It is usually temporary, but the complaint must be assessed and followed, and the patient should be told about this possibility beforehand.
Is double vision after filler an emergency?
It should be treated as a possible emergency, because it may be linked to vascular or orbital compromise. Any visual change after filler requires activating the emergency protocol and referring to an ophthalmology service without delay.
Can I wait a few days to see whether the diplopia goes away?
Not when a vascular cause is suspected or when the change comes with pain, vision loss or other warning signs. In mild, well-characterized cases, the decision rests with the professional together with an ophthalmic assessment.
Which specialist should assess diplopia?
The initial assessment is usually by ophthalmology, preferably at an ophthalmic emergency service when a vascular cause is suspected. Cases with neurological signs may require a general medical or neurological evaluation.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.